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Thesis Summary

This senior thesis focuses on sexual assault, a crime that has become a pressing issue in
America recently. Even here on USC’s campus, there are high rates of sexual assault/rape that
affect students of all ages, ethnicities, and backgrounds. Organizations such as “It’s On Us”
have been formed here on our campus in order to allow students to speak out against sexual
violence. There have also been cases in which USC students walking home from campus or the
Five Points area whom have been assaulted and raped in the past. This shows the predominance
sexual assault has not only nationwide, but within the college area.
The aftermath of sexual violence can consist of a multitude of things. Survivors of rape
can experience depression, post-traumatic stress, physical trauma, and infections.

One of the

infections that can be acquired through rape is Human Immunodeficiency Virus (HIV). HIV is a
chronic virus in which the body can not get rid of on its own, but drugs can help the suppress the
virus so that the host does not get more sick. HIV is transmitted through bodily fluids, meaning
it can be transmitted via rape. If a survivor of rape is at high risk of contracting HIV, a
prophylactic drug regimen can be taken within a certain time frame of the assault in order to
prevent the transmission of the virus. The regimen is around 28 days and can cost a few
thousand dollars if survivors are uninsured. This high cost can present a barrier to access of
prophylaxis for survivors.
Many states are more developed in this area of prophylactic treatment, specifically New
York and California. New York has clear guidelines that coincide with the Centers for Disease
Control and Prevention (CDC) 2016 guidelines for prescription of HIV prophylactic treatment.
This ensures that the state’s clinical decisions for survivors possibly exposed to HIV is sound.
Also, New York includes sections on reimbursement for provided services in the event that a
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survivor cannot pay for the medications. California is slightly more outdated than the CDC and
New York recommendations in regards to their regimen; however, the state includes
considerations for different populations such as pregnant women, children/adolescent survivors,
etc.
Currently, South Carolina has no standardized guidelines for the prescription and
financial obligations for HIV prophylactic treatment post sexual assault. With South Carolina’s
high rates of sexual assault and HIV/AIDS, there should be implementation of a program to
address these issues. In 2014, South Carolina Office of Victim Assistance (SOVA) contacted the
USC Immunology Clinic along with Palmetto Health Richland hospital in order to implement a
pilot program in order to provide funding for sexual assault survivors’ treatment preventing HIV.
Much communication had to take place in order for all aspects of the process to work efficiently.
Emergency departments first seeing sexual assault survivors had to ensure they referred the
survivors to the clinics for follow up. Also, the clinics and emergency department had to submit
paperwork to SOVA in a timely manner in order to be reimbursed for their services/medication.
This program ultimately helps to solve many issues around access to healthcare for those
who may be unable to afford but are in need. This research focuses around implementing this
program as solution for those survivors of sexual assault.
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Background/Purpose
In South Carolina, sexual assault is a significant issue. Untreated survivors of sexual assault
have the potential to contract multiple infectious diseases, such as HIV. Effective post-exposure
prophylaxis (PEP) can prevent HIV transmission; however many survivors experience financial
barriers to afford PEP, such as limited resources or limited/no health insurance. South Carolina
has minimal measures set in place for sexual assault survivors who cannot afford PEP.
Considering South Carolina’s high rates of sexual assault and HIV, this issue must be addressed.
Methods
State guidelines and policies for New York, California, and South Carolina were researched to
compare current HIV PEP guidelines. Additional methods utilized included observation and
interviews with key stakeholders.
Results
SOVA, the state agency providing help to sexual assault survivors, in cooperation with local
hospitals and infectious disease providers, initiated a pilot program in 2014 to address PEP
funding for sexual assault survivors. This program will ultimately help decrease incidences of
HIV transmission via sexual assault.
Conclusion/Implications
Reducing HIV infections associated with sexual assault will improve quality of life statewide.
Although HIV is no longer fatal, it remains a chronic illness that requires lifelong treatment.
This pilot program reduces a major barrier to PEP and should achieve broad availability of PEP
for survivors
in need. The SOVA pilot program plans on seeing an initial 50 patients and then hopefully being
expanded statewide.

POST-EXPOSURE PROPHYLAXIS

6

The Problem: Sexual Violence
In February 2016, a female college student attending University of South Carolina in
Columbia, SC was sexually assaulted at 3:15am. According to The State, the armed perpetrator
forced the victim onto a street where he then assaulted her. The survivor made it back to her
residence, where her roommates helped her to seek out help at a nearby hospital (Cahill, 2016).
In the United States, over the past two decades, female sexual assault incidences have
actually declined. In 2005, the overall rate of sexual assault incidences against females 12 and
older decreased by 64%, compared to the total cases reported in 1995. The rate of sexual assault
against males was lower than against females, with male cases estimating at 0.1 per 1,000 people
and female cases at 2.1 per 1,000 people in 2010 (Planty et al., 2013). Although these numbers
reflect reduced sexual assault occurrences, sexual violence is still a predominant issue in the
United States. Roughly 1 in 6 women and 1 in 33 men have been survivors of
attempted/completed sexual assault in the United States (South Carolina Coalition, 2016).
Sexual violence does not discriminate against particular lifestyles, as shown by the case
at the University of South Carolina campus. These crimes happen on college campuses, in rural
areas, urban areas, and often, the survivor knows their perpetrator. In 2015, 5,152 survivors
sought help/treatment in South Carolina, and 2,545 of these survivors reported assault by a
friend, acquaintance, or family member (South Carolina Coalition, 2016). In the United States,
every 3 in 1,000 females in rural areas are estimated to be survivors of sexual violence,
compared to every 2.2 per 1,000 estimated female survivors in urban areas (Planty et al., 2013).
This reflects the possibility of sexual violence occurring in some of the most unlikely
circumstances.
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Sexual assault is often used as an umbrella term, as it can include many situations such as
molestation, victimizations, or rape. Rape is “the unlawful penetration of a person against the
will of the victim” (Planty et al., 2013). This includes situations such as vaginal/oral/anal
penetration of the survivor by the offender or penetration with a foreign object such as a bottle.
On the other hand, sexual assault includes attempted attacks or attacks such as fondling,
molestation, verbal harassment, or grabbing (Planty et al., 2013). Although these two terms are
distinguishable, it can remain difficult to decipher what happened in the situation. This could be
due to sexual assault survivors not remembering the encounter or not being willing to share.
Survivors of rape can experience a multitude of health complications. The Centers for
Disease Control (CDC) outlines several health consequences of sexual violence, including
contraction of Human Immunodeficiency Virus (HIV), sexually transmitted diseases (STIs),
cervical cancer, and chronic pain. At least 32, 000 pregnancies occur annually from rape.
Moreover, the psychological response ranges from denial or anger to withdrawal or guilt (CDC,
2016).
In an effort to reduce these complications, healthcare systems work to assist in ensuring
the individual’s safety after being sexually assaulted via rape. From running diagnostic tests,
physical exams, and offering support, healthcare professionals look to promote recovery for a
survivor of sexual assault. Sexual Assault Nurse Examiners (SANEs) are often one of first
providers to see a survivor of sexual assault. These providers are Registered Nurses who have
completed more training and become certified to assess sexual violence survivors. The SANE
assesses the patient, and then collaborates with other members of the healthcare team, such as the
ED physician or the OB/GYN for female survivors (International Association of Forensic
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Nurses, 2015). The physician will determine the needs of the patient as far as any immediate
medical concerns, prophylactic treatments, or therapy.
Unfortunately, the measures taken by hospitals and providers for sexual violence
survivors vary. States are not mandated to have one common measure in place by the federal
government. This presents further consequences for untreated survivors. Survivors of sexual
assault are potentially at risk for many infections or diseases, one of which is Human
Immunodeficiency Virus (Centers for Disease Control and Prevention, 2016).
Human Immunodeficiency Virus
Human Immunodeficiency Virus (HIV) weakens the body’s immune system. The virus
attacks the body’s CD4 cells, which are a specialized type of White Blood Cell (WBC), cells that
fight off infection. This immunosuppression makes it easier for those with HIV to contract other
infections and illnesses. HIV is spread person-to-person through bodily fluids, such as blood,
semen, vaginal fluids, or breast milk. Thus, HIV can be spread by unprotected anal or vaginal
sex, sharing used needles, or mother-to-child during pregnancy or breastfeeding. While there is
currently no cure for HIV, treatment options for patients include prescribed antiretrovirals,
medications that suppress viral replication. If left untreated, HIV can become Acquired
Immunodeficiency Syndrome (AIDS). AIDS is one of the latest stages of HIV. At this point,
the disease has almost fully destroyed the host’s immune system. HIV progression can be
slowed before becoming AIDS with proper treatment; however, it remain a challenging chronic
disease (U.S. Department of Health and Human Services, 2015).
The CDC outlines specific risk factors for HIV transmission. The top three highest risk
types of exposures are blood transfusions (9, 250 per 10, 000), receptive anal intercourse (138
per 10, 000), and needle sharing during injection drug use (63 per 10, 000). Lower exposure risks
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recognized were needle sticks, insertive anal intercourse, and receptive/insertive penile-vaginal
intercourse (CDC, 2016). Fortunately, HIV infection can be prevented with proper prophylactic
treatment and strict adherence to treatment guidelines. Survivors determined to be at high-risk
for contracting HIV can receive a medication regimen that helps prevent the contraction of HIV.
HIV post-exposure prophylaxis (PEP) is known to reduce rates of HIV infections in high-risk
situations (McDougal et al, 2014).
PEP: The Solution
Post-exposure prophylaxis (PEP) is defined as taking antiretroviral medications after a
possible exposure to HIV, such as sexual assault or sharing needles, in order to prevent infection
with HIV. According to the CDC guidelines, PEP must be started within the first 72 hours of
exposure in order to be effective in prevention. This is due to the window of opportunity in
which HIV replication is most likely prevented, typically between one hour and up to 48-72
hours after exposure. PEP is not guaranteed 100% effective, however, the quicker PEP is
started, the better the likelihood of prevention. Patients usually take a specific antiretroviral
therapy regimen for 28 days, followed by lab checkups for up to 6 months after completion
(CDC, 2016). These labs continue to check for the presence of HIV after the preventative
therapy.
PEP is divided into non-occupational PEP (nPEP) and occupational PEP (oPEP). nPEP
is used in order to reduce the risk of HIV transmission in situations outside of the work place,
such as unprotected sex, sharing needles, or contact with infected bodily fluids. oPEP, however,
describes prevention of HIV through work-related exposures, such as accidental needle sticks or
contact with blood. Although similar on a clinical level, the difference between nPEP and oPEP
often lies in the aspect of payment. Where as oPEP is often covered by workers’ compensation,
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nPEP is not (CDC, 2016). In other words, occupational exposures are likely to be addressed
immediately whereas treatment of non-occupational exposures may be delayed due to financial
implications.
The CDC most recently updated nPEP recommendations in 2016. In these updated
guidelines, there is “additional evidence regarding use of non-occupational post-exposure
prophylaxis (nPEP) from animal studies, human observational studies, and consideration of new
antitretroviral medications that were approved since the 2005 guidelines” (CDC, 2016). Some of
the additional features include updated medication regimens, use of rapid antigen-antibody HIV
tests and a recommended 3-drug therapy. The guidelines suggest a standard 28-day regimen
consisting of three drugs. The preferred 28-day therapy regimen for healthy adults and
adolescents is tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg once daily plus
raltegravir 400 mg twice daily or dolutegravir 50 mg daily (CDC, 2016). Medication
recommendations are also included for those with kidney impairment, children/adolescents, and
pregnant women. The CDC also discusses an individualized approach for cases where the HIV
status of the source is unknown. In these cases, high-risk behaviors as well as situational criteria
are investigated. These updates were made in effort to give providers nationwide a better idea of
how to approach nPEP for those at risk of contracting HIV.
New York’s nPEP
Many states in the U.S. have standard practices for possible HIV exposure in sexual
assault survivors. New York, for example, proves to be a developed state in this area. Last
updated in October 2014, the HIV Clinical Resource, implemented by the New York State
Department of Health AIDS Institute & Johns Hopkins University Division of Infectious
Disease, designed a preferred program for HIV prophylaxis for sexual assault survivors (HIV

POST-EXPOSURE PROPHYLAXIS

11

Clinical Resource, 2014). This plan includes the medication regimen necessary for assault
survivors to prevent HIV. Furthermore, the guidelines include recommendations when
considering the timing of post-exposure prophylaxis (PEP), the HIV status of the perpetrator, the
role of the sexual assault examiner, circumstantial evidence, follow-up visits and testing, and
payment methods (HIV Clinical Resource, 2014). New York’s detailed prophylaxis program
could potentially serve as a model for other states as well. The following is an overview of the
state of New York’s guidelines for HIV prevention post-sexual assault based on the HIV Clinical
Resource.
The medication regimen set in New York’s guidelines is tenofovir 300 mg &
emtricitabine 200 mg taken by mouth daily, along with either raltegravir 400 mg or dolutegravir
50 mg twice by mouth daily (HIV Clinical Resource, 2014). Changes can be made to these
medications dependent on the patient’s current health status. This regimen is also used in
diagnosed HIV patients on a daily basis for chronic treatment of HIV and prevention of AIDS
(U.S. Department of Health and Human Services, 2015).
Hospitals in the state of New York are required to have the initial 7 days of medication
on-site. This guarantees the start of prophylaxis within 2 hours of arrival to the ED for survivors
who present to the hospital after sexual assault, falling in the preferred window of treatment
commencement recommended by the CDC. If a survivor presents 36 hours or more after an
assault, the clinician should thoroughly assess the patient and the projected effectiveness of
beginning the regimen. Follow-up visits are to be scheduled in professional healthcare settings
within 24 hours after the patient’s first dose to reevaluate the patient, answer questions, and
reiterate the importance of medication adherence (HIV Clinical Resource, 2014). Survivors
receiving PEP according to New York’s guidelines should be treated in a nothing less than a
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professional healthcare setting (HIV Clinical Resource, 2014). This ensures all medical
necessities and personnel needed are involved and available. This is an important
recommendation considering in the wrong setting or with uneducated clinicians, PEP could be
ineffective (HIV Clinical Resource, 2014).
In addition, the prescribing health professional should consider various aspects of the
assault. Some circumstantial evidence could contribute to the necessity of PEP, for example, the
likelihood of exposure from the assault. High-risk exposures are “direct contact of the vagina,
penis, anus, or mouth with the semen, vaginal fluids, or blood of the alleged assailant” (HIV
Clinical Resource, 2014). Other situational assault exposures, such as blood/semen contact with
broken skin or mucous membranes, are considered risks that are more moderate but should still
be offered PEP. According to the CDC, low-risk/negligible exposure include kissing, biting and
spiting (CDC, 2016). In summary, according to the protocol, any possible contact with blood or
semen from the assault is grounds for prophylactic treatment (HIV Clinical Resource, 2014).
Another consideration is the HIV status of the survivor’s perpetrator; although more
often than not, the perpetrator’s HIV status cannot be easily determined. Survivors may attest to
knowing their attacker and their HIV status, but this should have not influence the clinician’s
course of treatment, although it may alter the survivor’s willingness to accept the treatment (HIV
Clinical Resource, 2014). Due to the perpetrator’s status being largely unknown, treatment is
started immediately in accordance with the circumstances of the assault, such as the route of the
transmission and extent of assailant/survivor contact. However, PEP should be stopped, after
patient consultation with the prescriber, if multiple HIV tests of the perpetrator return as negative
(HIV Clinical Resource, 2014).
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The New York guidelines also outline the payment/insurance coverage aspects of PEP.
The treatment is covered through various insurances, from private plans to Medicaid/Medicare.
A means of payment must be provided for the assault exam and the medication regimen, and
coverage for uninsured survivors can be difficult and expensive. New York’s Office of Violence
Services (OVS) helps to ensure patient’s access to PEP after the initial seven days so that the 28day course can be completed. In the event that the survivor cannot afford to continue PEP,
providers can apply for an “emergency award” through OVS. If OVS deems the care necessary,
they will reimburse the provider for services for the survivor. This helps ensure that prophylaxis
can be completed in recommended high-risk situations (HIV Clinical Resource, 2014).
With these guidelines, New York is effectively able to protect sexual assault survivors
potentially exposed to HIV. Rates of HIV have decreased from 2005-present. Programs set in
place by New York such as nPEP have likely contributed to this decline (New York State Health
Department, 2012).
California’s nPEP
California is another state that has clear recommendations for HIV PEP after sexual
assault. Prior to implementing a statewide PEP program, approximately 38% of counties in
California did offer a PEP program similar to New York’s. However, as rates of sexual assault
with potential HIV exposure increased, California determined that the entire state needed a
proper protocol. Their guidelines, “Offering HIV Prophylaxis Following Sexual Assault,” are
similar to New York’s guidelines, outlining the importance of the assault circumstances, HIV
status of the perpetrator, the timing of PEP, and the medication regimen chosen (Myles &
Bamberger, 2001).
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In “Offering HIV Prophylaxis Following Sexual Assault,” California focuses on the
circumstances of the assault situation, similarly to New York. Both states agree that determining
the likelihood of transmission from perpetrator to survivor is important in determining the need
for PEP thereafter. Unlike New York, however, California divides the risk of HIV transmission
to the survivor into three categories based on the type of contact: “no risk (i.e. kissing, object
penetration), possible risk (victim biting, oral penetration and ejaculation), and measurable risk
(anal/vaginal penetration, contaminated needle injection)” (Myles & Bamberger, 2001, p. 11).
Dependent upon the assessed risk category, PEP may or may not be indicated.
Another factor of California’s protocol is the assailant’s HIV status. California does not
recommend PEP if the perpetrator is known HIV negative (Myles & Bamberger, p. 14). On the
other hand, if the perpetrator is known HIV positive, PEP is then recommended/not
recommended based on the risk of transmission category. If the circumstances of the assault
indicate no risk of transmission, PEP is not recommended. If the survivor has a possible risk of
transmission, the provider then looks at situational co-factors that may have been present, such as
multiple assailants, presence of blood, presence of STDs, or ejaculation by the assailant (Myles
& Bamberger, 2001). For a possible risk situation with one or more of these co-factors present,
PEP would be encouraged. For a possible risk situation with none of these co-factors present,
PEP would be offered but not recommended. For a measureable risk situation, such as
vaginal/anal penetration, PEP would be recommended (Myles & Bamberger, 2001).
California’s “Offering HIV Prophylaxis Following Sexual Assault” additionally
considers high-risk behaviors the assailant may have previously engaged in, including “drug use,
homosexual men, multiple sex partners, known sex offenders, or those with a criminal
history/incarceration” (Myles & Bamberger, 2001, p. 15). If known to be present, these
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behaviors indicate a higher possibility that the assailant may be HIV positive (Myles &
Bamberger, 2001).
The following table is included in California’s recommendations. It summarizes where
PEP is recommended/offered/not indicated based on the risk category, situational co-factors, and
the assailant’s high-risk factors. Situational co-factors investigated are number of assailants,
presence of blood, STD status, or ejaculation, whereas the risk categories based on the type of
contact that occurred (kissing, anal/vaginal penetration, or biting).

Adapted from “Offering HIV prophylaxis following sexual assault: Recommendations for the state of California” by Myles, J.E.
& Bamberger, J., 2001, Housing and Urban Health of the San Francisco Department of Public Health, California HIV PEP after
Sexual Assault Task Force, & The California State Office of AIDS,p.16..

California’s protocol for initiation of PEP coincides with New York. The PEP guidelines
state, “in no case should PEP be offered after 72 hours following the assault” (Myles &
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Bamberger, 2001, p. 9). Also, optimal timing for initiation of PEP is within 1-2 hours of the
possible transmission via assault (Myles & Bamberger, 2001). After the conduction of animal
studies, PEP was shown to be ineffective after 72 hours of exposure and minimally effective
even after 24-36 hours. For survivors seeking medical attention 72 hours post-assault, HIVantibody testing and counseling is recommended, and if diagnostic tests are HIV-positive,
consults to HIV specialists are initiated (Myles & Bamberger, 2001).
Unlike New York’s guidelines, California also includes some pediatric guidelines.
California recommends that if the survivor is under the age of 12, a pediatric HIV specialist
should be consulted for care. The parents of the child should also be consulted before the
initiation of PEP (Myles & Bamberger, 2001). This helps to individualize care based on age
indications.
Another difference between New York and California’s PEP guidelines are the
medication regimens recommended. While New York’s regimen includes tenofovir,
emtricitabine, and either raltegravir or dolutegravir, California recommends zidovudine 300 mg
and lamivudine 150 mg twice daily for a total of 28 days. This difference in recommendations
can be attributed to the timing of each state’s most recent updates. Where New York has recently
updated their guidelines in 2014, California’s guidelines were written in 2001. California’s
guidelines go on to emphasize that two-medication therapy “is acceptable because it is used to
reduce the likelihood of transmission following exposure to HIV, not to treat established
infection” (Myles & Bamberger, 2001, p. 18). Survivors initiating PEP should be thoroughly
educated on medication adherence and side effects, as well as the schedule for follow-up testing
(U.S. Department of Health and Human Services, 2015).
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California’s recommendations also recognize the payment issue for PEP. Payment should
not inhibit any survivor from obtaining these medications if indicated. There are state sources of
payment, according to California, that can aid survivors in affording medication, such as the
Victim Witness Program or county health departments (Myles & Bamberger, 2001). According
to California’s guidelines, “the cost of PEP medications has prevented county rape treatment
programs from prescribing HIV PEP medication in the past” (Myles & Bamberger, 2001, p. 21).
This shows how affording medication proves to be a barrier in prescribing PEP, maybe not just
in California, but nationwide.
South Carolina’s Situation
South Carolina healthcare lacks a statewide policy for treatment of individuals who
experience non-occupational exposure to HIV. This is an immediate concern, considering South
Carolina’s high rates of reported sexual assault, as well as high rates of sexually transmitted
infections (STIs) and HIV. South Carolina’s Department of Health and Environmental Control
(DHEC) outlines statistics on South Carolina’s rates of STIs and HIV/AIDS. As of 2015, South
Carolina has 18, 120 HIV cases. Many healthcare disparities exist among the HIV-positive
population in South Carolina. For example, although African-Americans represent only
approximately one third of South Carolina’s population, 67% of persons living with HIV in 2015
were African-Americans. Young adults were more prominent in HIV infections, with 38% of
new HIV cases in 2015 occurring in individuals between the ages of 20-29 (South Carolina
DHEC, 2015). Also, according to SC DHEC, South Carolina falls at #13 among the 50 states for
highest number of AIDS cases. More specifically, compare to all U.S. Metropolitan areas,
Columbia, SC ranks 11th in highest rates of AIDS. These STI/ HIV/AIDS statistics paired with
the high rates of sexual assault in South Carolina pave the way for risk of HIV transmission.
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Currently, South Carolina has no standardized state source of funding for sexual assault
survivors in need of nPEP. This prevents many survivors from obtaining nPEP when indicated,
possibly contributing to more HIV infections due to sexual assault. In past years, sexual assault
survivors either had to have health insurance coverage or pay for nPEP medications out of
pocket. The CDC recommends tenofovir and emtricitabine once daily plus either raltegravir or
dolutegravir for HIV nPEP for 28 days. The estimated cost for this mediation regimen out of
pocket is between $3,300-$3,500 depending on the specific prescription (Panel on Antiretroviral
Guidelines, 2017). This was a barrier for many uninsured survivors to HIV nPEP for whom it
was indicated.
SOVA’s Response
South Carolina’s State Office of Victims Assistance (SOVA), a state funded entity
involved in aiding survivors of violent crime, noticed these incongruities in South Carolina
between sexual assault incidences and no access to nPEP. Gail Washington, a quality assurance
manager at SOVA, explains that “our crime victims, who were sexually assaulted/raped and who
presented to the ED with an expectation that medical assistance would be available, were instead
met with unrealistic challenges” (personal communication, November 1, 2016). According to
Washington, SOVA has been struggling for years to provide funding for survivors at risk for
contracting HIV (personal communication, November 1, 2016). This was brought to the SOVA
advisory board, prompting the organization to fund a pilot program for HIV non-occupational
PEP in survivors 18 and older. Prior to the origins of this pilot program, SOVA’s Sexual Assault
Program would occasionally retroactively reimburse survivors for costs associated with nPEP.
Survivors who could not pay up front for the medications were often left with inadequate
treatment. Washington states that with this emerging pilot program, “the service should be
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standardized and should be provided at no cost to all survivors of sexual assault who meet the
criteria for being ‘at risk’ for contracting HIV. The objective is to standardize the process for
survivors and to provide the service free of charge (personal communication, November 1,
2016). One of the goals for this pilot program was to provide survivors financial access to nPEP
when indicated. Funding from SOVA for uninsured patients or patients unable to afford nPEP
sets the program apart. Participating clinical organizations are to follow guidelines
recommended by the CDC regarding necessity of nPEP as well as the drugs prescribed, while
SOVA provides payment.
Organizations such as Palmetto Health Richland Hospital and the Medical University of
South Carolina (MUSC), observed these challenges with sexual assault and HIV transmission
risk as an ongoing issue. Therefore, a committee was created in July 2012 with Palmetto Health,
MUSC and SOVA representatives in order to address these issues and begin brainstorming the
beginnings of the nPEP program. This committee included SOVA employees, ED physicians,
hospital pharmacists, Sexual Assault Nurse Examiners (SANEs), laboratory specialists, clinic
providers, clinic administration, and case managers. The committee met periodically for almost
two years, creating standardized screening tools, protocols and algorithms for the program.
Palmetto Health-University of South Carolina Infectious Disease (PH-USC ID) clinic providers
and Medical University of South Carolina (MUSC) were chosen to host the pilot HIV PEP
program for sexual assault survivors. In summer 2014, the first survivor was accepted into the
program at PH-USC ID. One year later, MUSC accepted their first survivor. SOVA along with
PH-USC ID and MUSC had to collaborate extensively in order for this program to be a success.
Not only did both entities have to ensure that the program was clinically sound, but they also had
to ensure the financial aspects were sound as well. SOVA representatives worked diligently to
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affirm that uninsured survivors of sexual assault, if indicated for HIV nPEP, are financially
supported by SOVA. Furthermore, the hospitals must communicate with SOVA when they have
candidates for the program.
The Current Program Process
Similar to California and New York, the ED staff at the SOVA pilot sites follows specific
guidelines in order to prescribe a patient nPEP. First, the ED nurse/physician determines
whether or not a significant sexual exposure to potentially HIV infected fluid occurred (i.e. anal,
oral, vaginal). As part of the general physical exam/testing, the survivor also receives fourth
generation antigen-antibody testing to ensure he/she is not already previously infected with HIV.
If not, nPEP is not recommended for this patient and no follow-up is indicated. If a significant
exposure occurred, the timing of exposure is then determined. If the exposure was 72 hours ago
or more, which is outside the recommended window for nPEP, nPEP is not prescribed but the
patient will be encouraged to have follow-up HIV testing. If the patient presents within 72 hours
of exposure, it is then determined if the source of exposure is available/consents to be tested. If
the assailant is available, rapid HIV testing is done on the source, and if found to be positive, a
28 day regimen nPEP is prescribed for the patient. If the source is unavailable/does not consent
to be tested, the ED personnel will use certain determinants to define the source as either high
risk/not high risk. If the source is high risk or unknown/unsure, the 28 day regimen is prescribed
for the patient. If the source is not high risk, nPEP is not recommended (CDC, 2016). Once
prescribed, the patient will receive the first five days of medication from the ED pharmacy.
Follow-up is conducted at the outpatient clinic.
Follow-Up
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The patient will then follow up in the PH-USC ID clinic for the next ten days’ worth of
medication. Finally, after those ten days, the clinic will contact the patient and assess adherence
to the regimen. The patient is then prescribed the last thirteen days of medication. This process
helps ensure that the patients being distributed medication are adhering to the regimen,
minimizing the distribution of expensive medication that may not be used. This also gives the
patient time to consult with providers with any questions or concerns they may have with nPEP.
Lab testing is then completed at the clinic at intervals of 6 weeks and 6 months after HIV nPEP
is initiated (SOVA, 2016). This is to ensure that nPEP is effective and patients remain HIV
negative.
These guidelines parallel those recommended by the CDC. If the source is later
determined to be uninfected or the patient is found to already have HIV, nPEP can be
discontinued (CDC, 2016). The CDC also states that after the initial 72 hour window postexposure, nPEP is not suggested; rather, follow-up testing should be done to determine if HIV
was transmitted. A case-by-case basis is also suggested, specifically if the assailant is unknown,
relying on factors such as method of transmission, risk factors of the assailant, and number of
assailants involved (CDC, 2016).
Funding for nPEP
Financially, the survivor is not responsible for any cost associated with nPEP after sexual
assault in this pilot program. Follow up is needed not only in the clinical setting but also with
SOVA as well in order for the ED/associated clinical settings to be reimbursed for their provided
services to survivors. The clinics/ED must submit applications for the survivors presenting for
treatment and qualifying for nPEP. Then, reimbursement decisions are made by SOVA. Rules
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and regulations outlined by SOVA for reimbursement of medications and services include the
following:
•

"All patients in the HIV nPEP and Follow-Up program will have been a victim of sexual
assault,

•

The patient will have been identified as a ‘high-risk’ patient,

•

The crime will have happened within 72 hours [prior to] the initial ED visit,

•

The patient must visit the clinic within 5 to 7 days of the initial ED visit,

•

The victim will have been referred by a SANE, FNE, or ER Physician,

•

The victim was not confined in any correctional facility at the time of the crime,

•

The crime happened in South Carolina,

•

And all applications and billing statements will be submitted to SOVA within 30 days
from the date of service”

(State Office of Victim Assistance, 2016).
Once hospitals submit the application, they are reimbursed for the prescription costs, follow-up
treatment and other associated services provided (State Office of Victim Assistance, 2016).
Within SOVA, funding for overall care for the patient is split between two areas of
SOVA. Washington explains “SOVA’s Sexual Assault Program covers the cost of nPEP
treatment and SOVA’s Compensation Program covers the cost of the follow-up care, lab work
and clinic visits” (personal communication, November 1, 2016).

As far as law enforcement

goes, the survivor of sexual assault has no obligation to report the crime in order to receive
services. This is part of SOVA’s policy, and EDs/clinics will still be reimbursed for services
regardless of law enforcement involvement.
Nursing Role Considerations: The SANE
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One of the key personnel in caring for sexual assault survivors and nPEP initiation is the
Sexual Assault Nurse Examiner (SANE). SANEs are the first provider to assess survivors in the
ED and ultimately provide the patient with pertinent information alongside the primary provider.
Gina Dyer-Goss is one of the main SANEs involved in the SOVA pilot program. She has been a
SANE at Palmetto Health Richland hospital for 10 years. After receiving a bachelor’s in
criminal justice then going back for her nursing degree, Dyer-Goss decided that she wanted more
of a one on one, personal experience with patients.
SANE certification includes many aspects more than just nursing. During training,
SANEs must go through didactic courses as well as meet with law enforcement, judicial systems,
and forensic teams. This ensures that SANEs are prepared to deal with all facets of a sexual
assault rather than just nursing care. These types of nurses are the first line for sexual assault
cases that come into the Emergency Department (ED). They assess the patients and help refer
them to appropriate follow up care. According to Dyer-Goss, the hardest part about the job is
“dealing with these traumatic cases but not always getting to see them through. The job
sometimes lacks closure.” Survivors who come in qualifying for HIV nPEP follow up with the
clinic after intial ED treatment, and the SANEs do not receive notification if they followed with
the nPEP regimen. Dyer-Goss says that it is difficult for the SANEs to keep track of patients who
show up to the clinic for the follow up medications and who do not.
She also went on to describe the patient interaction with survivors of sexual assault at risk
for contracting HIV. SANEs, forensic nurse examiners and physicians screen sexual assault
survivors who present to the ED to see how high risk he/she is for contracting HIV. Each
survivor is treated in a standardized way and given opportunity for treatment as recommended by
healthcare personnel. According to Dyer- Goss, the first thing in question is always the time
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frame. If the assault occurred outside the 72-hour window, the patient should be referred to other
services such as follow up HIV lab testing, and not recommended for nPEP. Next, the point of
contact and type of assault is determined (i.e. vaginal, anal, oral), as well as assessment of the
assaulter. Depending on the screening, if the survivor presents on the higher risk side, nPEP is
strongly encouraged for the patient, and based on the patient’s choice, they are either entered into
the program or not. Some patients are compliant with starting/completing nPEP, while others
do not want nPEP due to the possibility of associated side effects (i.e. nausea/vomiting), says
Dyer-Goss. This is another hardship in the job, she says, as she has seen some patients
encouraged for nPEP refuse it.
SANEs play a vital role in establishing the necessity for nPEP alongside forensic nurse
examiners and ED physicians. In addition to patient care and assisting the survivor, SANEs are
responsible for paperwork involved with reimbursement from SOVA. After the survivor
receives five days of medication in the ED and clinic referral, SANEs help to fill out the proper
paperwork that is billed to SOVA, as explained before. SOVA then reviews the paperwork and
reimburses the healthcare facility for their services.
Conclusions
As a pilot program, the SOVA funding for nPEP for sexual assault survivors will remain
active for 50 survivors. So far, since the first survivor seen in summer 2014, SOVA has provided
services and funding through nPEP for approximately 30 survivors. After the first 50 survivors,
SOVA plans to implement the program as a standard protocol, as carried out in states such as
New York and California. Considering South Carolina’s high numbers of sexual assault and
high rates of HIV, this program would be beneficial to implement statewide. Not only is the
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program clinically sound, as compared to guidelines recommended by the CDC, but also funding
provided by SOVA will allow for more survivors to have access who normally would not.
Gail Washington ultimately foresees inviting other facilities into the nPEP program, i.e.
areas of South Carolina such as Spartanburg Regional Medical Center and Aiken Regional
Medical Center, progressing toward implementing the program statewide. “To ensure that the
nPEP program can succeed outside of a controlled pilot program, SOVA will use hospitals that
have trained providers (Forensic Nurse Examiners or Physicians with experience in collecting
forensic evidence) on staff, who would be able to perform the appropriate exams, follow the
protocol, and work out the processes with clinic, lab and pharmacy,” says Washington,
explaining how this will ensure program success (personal communication, November 1, 2016).
Although new, the SOVA nPEP program could reduce South Carolina’s rates of HIV
transmission; however, there would be implications to implementing statewide. SOVA would
have to increase funding as well as ensure that the participating institutions are properly staffed.
Also, as Gina Dyer-Goss mentioned, there are patients who do not adhere to the program after
their initial ED visit. Some patients follow up in order to complete their nPEP regimen, while
other may not. Furthermore, there are many sexual assault survivors, according to the SOVA
staff, that do not initially present to the ED at all. This is a barrier to providing nPEP to sexual
assault survivors. Despite these challenges, moving towards a statewide-standardized program
to fund nPEP for sexual assault survivors has the potential to positively impact both individuals
and the health of South Carolina. Preventing as many sexual assault-related HIV transmissions
as possible is the ultimate goal of the SOVA nPEP program.
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